In addition, KD feeding for 3 months in APP/PS1 and Tg4510 (a mouse model replicating the forebrain-directed tau pathology seen in AD patients) murine models again ameliorated their deteriorated motor performance but not cognitive deficits, markers of neuroinflammation, or amyloid and tau deposition [68]. This evidence concerns the gene MAPT and amyloidosis.